Bristol Myers (BMY) Reports Q4 Profit of $1.09B, EPS $1.26 vs. $1.15 Estimate

Bristol Myers Squibb Co. (BMY) reported fourth-quarter profit of $1.09 billion, or 53 cents per share, on an adjusted basis. Revenue for the period reached $12.5 billion, exceeding the $12.25 billion average estimate. Results surpassed analyst expectations of $1.15 and $1.20 per share. The company now expects full-year 2026 earnings of $6.05 to $6.35 per share and revenue of $46 billion to $47.5 billion. (February 5, 2026) Since the start of the year, BMY shares have gained nearly 7%, outperforming the S&P 500’s 0.5% rise and contrasting with a 2.5% year-to-date decline. The stock is up on the earnings beat and strong revenue guidance.